← Back to Analyst Consensus 
NAMS Buy
NewAmsterdam Pharma Co N.V.
Current Price —
Implied Upside —
Analysts 23
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 5, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 8, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 30, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Feb 19, 2026 | Guggenheim | maintain | Buy → Buy | $45 | 52% |
| Feb 18, 2026 | Needham | maintain | Buy → Buy | $48 | 50% |
| Jan 21, 2026 | RBC Capital | maintain | Outperform → Outperform | $47 | 55% |
| Dec 16, 2025 | Stifel | maintain | Buy → Buy | $50 | 53% |
| Dec 2, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $37 | 54% |
| Nov 6, 2025 | RBC Capital | maintain | Outperform → Outperform | $44 | 55% |
| Nov 5, 2025 | Needham | maintain | Buy → Buy | $46 | 50% |
| Oct 17, 2025 | Citigroup | maintain | Buy → Buy | $50 | 54% |
| Aug 25, 2025 | Wells Fargo | initiate | — → Overweight | $45 | 54% |
| Aug 7, 2025 | RBC Capital | maintain | Outperform → Outperform | $39 | 55% |
| Jul 17, 2025 | Goldman Sachs | initiate | — → Neutral | $27 | 54% |
| Jun 17, 2025 | Citigroup | initiate | — → Buy | $42 | 54% |
| Jun 12, 2025 | Needham | reiterate | Buy → Buy | $40 | 50% |
| Jun 10, 2025 | Stifel | initiate | — → Buy | $44 | 53% |
| May 8, 2025 | Needham | maintain | Buy → Buy | $40 | 50% |
| Apr 8, 2025 | Needham | reiterate | Buy → Buy | $42 | 50% |
| Feb 27, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $52 | 55% |
| Feb 27, 2025 | Needham | maintain | Buy → Buy | $42 | 50% |
| Jan 28, 2025 | RBC Capital | reiterate | Outperform → Outperform | $40 | 55% |
| Jan 24, 2025 | RBC Capital | reiterate | Outperform → Outperform | $40 | 55% |
| Jan 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $48 | 44% |
| Dec 30, 2024 | HC Wainwright & Co. | initiate | — → Buy | $48 | 44% |
| Dec 11, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $47 | 55% |
| Dec 5, 2024 | Needham | reiterate | Buy → Buy | $36 | 50% |
| Nov 21, 2024 | Needham | reiterate | Buy → Buy | $36 | 50% |
| Nov 11, 2024 | Needham | reiterate | Buy → Buy | $36 | 50% |
| Nov 7, 2024 | Needham | reiterate | Buy → Buy | $36 | 50% |
| Sep 23, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $37 | 54% |
| Sep 5, 2024 | RBC Capital | reiterate | Outperform → Outperform | $31 | 55% |
| Aug 28, 2024 | Needham | initiate | — → Buy | $36 | 50% |
| Jul 30, 2024 | RBC Capital | reiterate | Outperform → Outperform | $31 | 55% |
| Jun 7, 2024 | RBC Capital | reiterate | Outperform → Outperform | $31 | 55% |
| May 15, 2024 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Mar 14, 2024 | Scotiabank | initiate | Sector Outperform → Sector Outperform | $35 | 55% |
| Mar 13, 2024 | Scotiabank | initiate | — → Sector Outperform | $35 | 55% |
| Feb 29, 2024 | RBC Capital | maintain | Outperform → Outperform | $31 | 55% |
| Jan 18, 2024 | Guggenheim | initiate | — → Buy | $30 | 52% |
| Jan 16, 2024 | Piper Sandler | initiate | — → Overweight | $37 | 54% |
| Oct 30, 2023 | RBC Capital | initiate | — → Outperform | $25 | 55% |
| Apr 3, 2023 | Credit Suisse | maintain | — → Outperform | $22 | — |
| Jan 6, 2023 | Credit Suisse | initiate | — → Outperform | $21 | — |
| Dec 20, 2022 | SVB Leerink | initiate | — → Outperform | $19 | — |
| Dec 19, 2022 | William Blair | initiate | — → Outperform | $0 | 48% |
| Dec 19, 2022 | Jefferies | initiate | — → Buy | $24 | 52% |
Price Target Trend
Apr 25, 2026 Latest: $49.97 Oct 25, 2026
EPS Estimates
0y $-1.66
Lo: $-1.87 Hi: $-1.43
12 analysts +1y $-1.55
Lo: $-2.74 Hi: $1.88
12 analysts ▲1
0q $-0.44
Lo: $-0.54 Hi: $-0.29
13 analysts ▲1
+1q $-0.39
Lo: $-0.55 Hi: $-0.23
13 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days